NCT/Study#
NCT06541262 /
BCC021
Phase I/II study of Silmitasertib (CX-4945) in combination withchemotherapy in children and young adults with relapsed refractory solid tumors
DISEASE GROUP:
Pediatric Oncology
current phase:
Phase I/II
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
